New collaboration between Foundation Medicine and H3 aims to develop precision cancer therapies.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
23andMe and FDA make significant progress in direct-to-consumer testing.
Tel Aviv University researcher identifies novel genetic mutations through DNA sequencing of afflicted child and family.
UC Berkeley & UC San Francisco launch gene-editing initiative.
Merck join the SGC with multi-million dollar contribution. Merck have announced a contribution of C$7.5 million to the Structural Genomics Consortium (SGC), joining as a member organisation. The supported project focus on per-competitive research to develop small inhibitory molecules called chemical probes to study epigenetic mechanisms of regulation. In collaboration with leading clinical institutions in […]
The long battle over BRCA1 and BRCA2 patent infringement finally comes to an end.
Roche are planning on spending $1 billion to take majority control of Foundation Medicine.